Gene editing for cell engineering: trends and applications
The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Gene editing with all its own advantages in molecular biology applications has made easy manipulation of various production hosts with the discovery and implementation of modern gene editing tools such as Crispr (Clustered regularly interspaced short palindromic repeats), TALENs (Transcription activator-like effector nucleases) and ZFNs (Zinc finger nucleases). With the advent of these modern tools, it is now possible to manipulate the genome of industrial production hosts such as yeast and mammalian cells which allows developing a potential and cost effective recombinant therapeutic protein. These tools also allow single editing to multiple genes for knocking-in or knocking-out of a host genome quickly in an efficient manner. A recent study on "multiplexed" gene editing revolutionized the knock-out and knock-in events of yeast and CHO, mammalian cells genome for metabolic engineering as well as high, stable, and consistent expression of a transgene encoding complex therapeutic protein such as monoclonal antibody. The gene of interest can either be integrated or deleted at single or multiple loci depending on the strategy and production requirement. This review will give a gist of all the modern tools with a brief description and advances in genetic manipulation using three major tools being implemented for the modification of such hosts with the emphasis on the use of Crispr-Cas9 for the "multiplexing gene-editing approach" for genetic manipulation of yeast and CHO mammalian hosts that ultimately leads to a fast track product development with consistent, improved product yield, quality, and thus affordability for a population at large.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genome engineering using the CRISPR-Cas9 system
Ran, F. A., Hsu, P. D., Wright, J., Agarwala, V., Scott, D. A., & Zhang, F. (2013) · Nature Protocols · doi:10.1038/nprot.2013.143 · Cited by 11,133
The new frontier of genome engineering with CRISPR-Cas9
Doudna, J. A., & Charpentier, E. (2014) · Science · doi:10.1126/science.1258096 · Cited by 7,062 · cited 5×
“This is then further processed into small Cr-RNA and Trans-activating Cr-RNA.[1,2] The Cas9 protein associated with Crispr has two domains RuvC and HNH which are the cleavage domains for Cas9 system.”
BackgroundInfluentialWang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.04.025 · Cited by 3,495 · cited 2×
“[79] Consequently, attempting multiplexing is worthwhile for generating multiple gene disruptions in CHO genome since Crispr-Cas9-based editing allow high efficiency of disruption event.[61,67] The use of the Crispr-Cas9 complex also reduces the workforce involved in generating KO and KI CHO cells.”
BackgroundGenetic screens in human cells using the CRISPR-Cas9 system
Wang, T., Wei, J. J., Sabatini, D. M., & Lander, E. S. (2014) · Science · doi:10.1126/science.1246981 · Cited by 2,856
Gasiunas, G., Barrangou, R., Horvath, P., & Siksnys, V. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208507109 · Cited by 2,769
A TALE nuclease architecture for efficient genome editing
Miller, J. C., Tan, S., Qiao, G., Barlow, K. A., Wang, J., Xia, D. F., Meng, X., Paschon, D. E., Leung, E., Hinkley, S. J., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1755 · Cited by 2,098 · cited 1×
“[76] To overcome such undesired events, the newly developed more specific and efficient gene-editing tools such as ZFNs, TALENs and meganucleases have been successfully employed for the genome editing of human and animal cells including CHO line.[77,78] Recently, scientists have explored a novel gene-editing tool Cris…”
BackgroundProduction of recombinant protein therapeutics in cultivated mammalian cells
Wurm, F. M. (2004) · Nature Biotechnology · doi:10.1038/nbt1026 · Cited by 2,032 · cited 3×
“[81,82] This often leads to the development of heterogeneous and unwanted phenotypes, resulting in inconsistent protein production termed as “position effect variation”.[82,83] However, these clones often show reduced and inconsistent protein production over a period due to variation in”
BackgroundRNA-guided genetic silencing systems in bacteria and archaea
Wiedenheft, B., Sternberg, S. H., & Doudna, J. A. (2012) · Nature · doi:10.1038/nature10886 · Cited by 1,851 · cited 4×
“[1] This offers a wide range of applications such as gene KO, gene correction and gene silencing,[9,12] and consequently giving hopes for the future of a potent and cost-effective biopharmaceuticals development as well as disease-free populations caused by the genetic mutations.”
BackgroundMethodInfluentialRational design of highly active sgRNAs for CRISPR-Cas9-mediated gene inactivation
Doench, J. G., Hartenian, E., Graham, D. B., Tothova, Z., Hegde, M., Smith, I., Sullender, M., Ebert, B. L., Xavier, R. J., & Root, D. E. (2014) · Nature Biotechnology · doi:10.1038/nbt.3026 · Cited by 1,617 · cited 2×
“When two complimentary annealed nucleotides are required to produce any number of gRNAs for target specific DNA manipulation.[46] 3.”
BackgroundYang, H., Wang, H., Shivalila, C. S., Cheng, A. W., Shi, L., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.08.022 · Cited by 1,596 · cited 1×
“endogeneous reporter genes.[55] The Crispr-Cas9”
Cited by
Tripathi, N. K., & Shrivastava, A. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00420 · Cited by 575
Bioremediation through microbes: systems biology and metabolic engineering approach
Dangi, A. K., Sharma, B., Hill, R. T., & Shukla, P. (2019) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2018.1500997 · Cited by 318
Self-citationJagadevan, S., Banerjee, A., Banerjee, C., Guria, C., Tiwari, R., Baweja, M., & Shukla, P. (2018) · Biotechnology for Biofuels · doi:10.1186/s13068-018-1181-1 · Cited by 275
Self-citationEngineering PGPMOs through Gene Editing and Systems Biology: A Solution for Phytoremediation?
Basu, S., Rabara, R. C., Negi, S., & Shukla, P. (2018) · Trends in Biotechnology · doi:10.1016/j.tibtech.2018.01.011 · Cited by 138
Self-citationMicrobes' role in environmental pollution and remediation: a bioeconomy focus approach
Maglione, G., Zinno, P., Tropea, A., Mussagy, C. U., Dufossé, L., Giuffrida, D., & Mondello, A. (2024) · AIMS Microbiology · doi:10.3934/microbiol.2024033 · Cited by 82
Metadata
- Authors
- Gupta, S. K., & Shukla, P.
- Venue
- Critical Reviews in Biotechnology
- Publisher
- Informa UK Limited
- Published
- 2016-08-18
- Volume
- 37
- Issue
- 5
- Pages
- 672-684
- ISSN
- 0738-8551 (ISSN-L)
- 1549-7801
- OpenAlex
- W2517879681
- Cited by
- 127
- References
- 25
- FWCI
- 6.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Gene editing for cell engineering: trends and applications. https://app.cochat.ai/papers/10.1080/07388551.2016.1214557
- The paper
- Gupta, S. K., & Shukla, P. (2017). Gene editing for cell engineering: trends and applications. Critical Reviews in Biotechnology. https://doi.org/10.1080/07388551.2016.1214557
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.